Position in IDXX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,240,238
-$758,054 QoQ
Shares Held
6,155
+4.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#426
of 1,286 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Faithward Advisors, LLC holds $9,367,135 across 2 Diagnostics & Research names. IDXX ranks #2 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
22,571 | $6,126,897 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
This page
|
6,155 | $3,240,238 |
All Filings in IDXX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,240,238 | 6,155 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $3,998,292 | 5,910 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,680,645 | 5,761 | Shares | Sole | 2025-11-19 | |
| 2022-06-30 | $246,212 | 702 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $506,030 | 925 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $688,090 | 1,045 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,347,035 | 2,166 | Shares | Other | 2021-11-16 | |
| 2021-06-30 | $1,726,025 | 2,733 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $4,146,412 | 8,474 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $4,439,345 | 8,881 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $4,220,822 | 10,737 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,678,367 | 14,170 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,778,735 | 11,471 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||